Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

Bernstein Initiates Coverage On Ambev with Outperform Rating, Announces Price Target of $3.74

Author: Benzinga Newsdesk | May 24, 2023 08:25am
Bernstein analyst Nadine Sarwat initiates coverage on Ambev (NYSE:ABEV) with a Outperform rating and announces Price Target of $3.74.

Posted In: ABEV

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist